YuYu Pharma signed 10 antihistamine CMO contracts this month

Kim Minyoung / approved : 2024-04-16 03:18:29
  • -
  • +
  • 인쇄

(Photo= YuYu Pharma)

 

[Alpha Biz= Reporter Kim Minyoung] YuYu Pharma announced on the 15th that it has signed a new consignment production contract with 10 pharmaceutical companies this month. The new growth engine, the CMO (medicine consignment production) business, is cruising as it has signed a series of contracts.

YuYu Pharma recently signed a contract with six companies for Fexofenadine 120mg, which was approved by the Ministry of Food and Drug Safety, including Kyungnam Pharmaceutical, Non-preservative Drug, CMG Pharmaceutical, Nexfarm Korea, Eden Pharma and Medica Korea. Fexofenadine 120mg is a differentiated item that improves patient convenience by reducing formulation size by 44% compared to existing products.

Launched last year, Fexofenadine 60mg has signed additional contracts with four other companies: CMG Pharmaceutical, Medica Korea, Edenpharma and Hutex Pharmaceutical. As a result, Fexofenadine 60mg consignment production has increased to a total of 10 companies, including existing Samjin Pharmaceutical, Ahn-Gook Pharmaceutical, Daewoo Pharmaceutical, Non-preservative Drug, Nex Pharm Korea and Dibio.

 

 

Alphabiz Kim Minyoung (kimmy@alphabiz.co.kr)

주요기사

Paris Croissant Issues Voluntary Recall of “Dried Persimmon Pound Cake” Due to Allergen Labeling Omissio2025.09.18
Hyundai Motor Group Restores Vehicle Control Apps After 10-Hour Outage2025.09.18
HMM Completes Share Buyback Worth KRW 2.14 Trillion2025.09.18
Gyeonggi Police Arrest Two Chinese Nationals Over KT Mobile Payment Hacking Scheme2025.09.18
Financial Services Commission Imposes ₩3.66 Billion in Fines on STX and STX Marine Service for Accounting Violations Related to Overseas Litigation2025.09.18
뉴스댓글 >